26 Recruiting Breast Cancer Clinical Trials in Arizona
Explore active breast cancer research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Breast Cancer Studies in Arizona
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
📍 Research Site — Gilbert, Arizona
View Study & Checklist ➔The OPBC-07/microNAC Study
📍 Valleywise Health Medical Center — Phoenix, Arizona
View Study & Checklist ➔OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
📍 Clinical Trial Site — Tucson, Arizona
View Study & Checklist ➔DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
📍 Ironwood Cancer & Research Centers - Chandler II — Chandler, Arizona
View Study & Checklist ➔Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
📍 Dignity Health St Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔Adaptive Symptom Self-Management Immunotherapy Study
📍 Valleywise Health Medical Center — Phoenix, Arizona
View Study & Checklist ➔Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
📍 Research Site — Casa Grande, Arizona
View Study & Checklist ➔STOP-HER2: Stopping Trastuzumab in HER2+ MBC
📍 Mayo Clinic Hospital Arizona — Phoenix, Arizona
View Study & Checklist ➔A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Excision Followed by Radiofrequency Ablation for Breast Cancer
📍 University of Arizona — Tucson, Arizona
View Study & Checklist ➔Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
📍 Mayo Clinic of Scottsdale — Scottsdale, Arizona
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
📍 City of Hope - Phoenix — Goodyear, Arizona
View Study & Checklist ➔E-Mindfulness Approaches for Living After Breast Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
📍 University of Arizona — Tucson, Arizona
View Study & Checklist ➔A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
📍 Arizona Oncology Associates, PC - NAHOA — Prescott, Arizona
View Study & Checklist ➔A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
📍 Arizona Oncology Associates — Tucson, Arizona
View Study & Checklist ➔Breast Cancer, Reasoning, and Activity Intervention
📍 Mayo Clinic in Arizona — Phoenix, Arizona
View Study & Checklist ➔Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
📍 Mayo Clinic-Comprehensive Cancer Center-Breast Clinic — Phoenix, Arizona
View Study & Checklist ➔Community-led Navigation to Address Disparities in Mammography Among Native American Women
📍 Navajo Nation Center for Indigenous Health — Chinle, Arizona
View Study & Checklist ➔A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔